NMTR P/E Ratio
P/E Ratio as of Jun 12, 2025: -120.83
Average-117.25
Median-116.84
Minimum-124.83
Maximum-111.46
-120.83
Past Month-3.82 (3.26%)
The P/E ratio for NMTR is -120.83 as of Jun 12, 2025. This represents a increase of 527.69% compared to its 12-month average P/E ratio of -19.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
9 Meters Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
9 Meters Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing 9 Meters Biopharma to industry peers.
9 Meters Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
9 Meters Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing 9 Meters Biopharma to industry peers.
NMTR P/E Ratio Insights
See 9 Meters Biopharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NMTR
Order type
Buy in
Order amount
Est. shares
0 shares
NMTR P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $6.42 | -111.46 |
| May 1, 2025 | $6.35 | -5.57 |
| Apr 1, 2025 | $6.49 | -5.69 |
| Mar 3, 2025 | $6.86 | -6.02 |
| Feb 3, 2025 | $5.99 | -17.98 |
| Jan 2, 2025 | $6.14 | -18.69 |
NMTR End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -120.83 | +555.26% |
| 2024 | -18.44 | +295.71% |
| 2023 | -4.66 | +27.67% |
| 2022 | -3.65 | -136.61% |
| 2021 | 9.97 | -373.90% |
| 2020 | -3.64 | — |
FAQs About 9 Meters Biopharma (NMTR) P/E ratio
The latest P/E ratio of NMTR is -120.83, as of Jun 12, 2025. This is calculated based on its current stock price and earnings per share (EPS).
9 Meters Biopharma’s last 12-month average P/E ratio is -19.25, compared to its current P/E ratio of -120.83. This reflects a increase of 527.69%.
9 Meters Biopharma’s current P/E ratio of -120.83 is higher than its last 12-month average P/E of -19.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
9 Meters Biopharma’s average P/E ratio over the last 3 years is -9.94. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
9 Meters Biopharma’s average P/E ratio over the last 5 years is -1.27. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.